Free Trial

Knight Therapeutics (GUD) Competitors

C$6.11
-0.03 (-0.49%)
(As of 05/17/2024 04:00 PM ET)

GUD vs. ACB, OGI, WEED, CPH, CRDL, CRON, TLRY, EXE, KSI, and VHI

Should you be buying Knight Therapeutics stock or one of its competitors? The main competitors of Knight Therapeutics include Aurora Cannabis (ACB), Organigram (OGI), Canopy Growth (WEED), Cipher Pharmaceuticals (CPH), Cardiol Therapeutics (CRDL), Cronos Group (CRON), Tilray Brands (TLRY), Extendicare (EXE), kneat.com (KSI), and Vitalhub (VHI). These companies are all part of the "medical" sector.

Knight Therapeutics vs.

Knight Therapeutics (TSE:GUD) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their community ranking, risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

13.7% of Knight Therapeutics shares are held by institutional investors. Comparatively, 7.1% of Aurora Cannabis shares are held by institutional investors. 46.4% of Knight Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Knight Therapeutics had 2 more articles in the media than Aurora Cannabis. MarketBeat recorded 2 mentions for Knight Therapeutics and 0 mentions for Aurora Cannabis. Knight Therapeutics' average media sentiment score of 0.10 beat Aurora Cannabis' score of 0.00 indicating that Knight Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Knight Therapeutics Neutral
Aurora Cannabis Neutral

Knight Therapeutics has a beta of 0.46, suggesting that its stock price is 54% less volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 2.93, suggesting that its stock price is 193% more volatile than the S&P 500.

Knight Therapeutics presently has a consensus target price of C$6.75, indicating a potential upside of 10.47%. Aurora Cannabis has a consensus target price of C$2.26, indicating a potential upside of ∞. Given Aurora Cannabis' higher possible upside, analysts plainly believe Aurora Cannabis is more favorable than Knight Therapeutics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Knight Therapeutics
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Aurora Cannabis
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33

Aurora Cannabis has a net margin of 151.71% compared to Knight Therapeutics' net margin of -5.25%. Knight Therapeutics' return on equity of -2.21% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
Knight Therapeutics-5.25% -2.21% 0.21%
Aurora Cannabis 151.71%-137.28%-8.26%

Aurora Cannabis received 418 more outperform votes than Knight Therapeutics when rated by MarketBeat users. However, 74.32% of users gave Knight Therapeutics an outperform vote while only 63.16% of users gave Aurora Cannabis an outperform vote.

CompanyUnderperformOutperform
Knight TherapeuticsOutperform Votes
110
74.32%
Underperform Votes
38
25.68%
Aurora CannabisOutperform Votes
528
63.16%
Underperform Votes
308
36.84%

Aurora Cannabis has lower revenue, but higher earnings than Knight Therapeutics. Knight Therapeutics is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Knight TherapeuticsC$332.21M1.86-C$17.44M-C$0.16-38.19
Aurora CannabisC$275.88M0.00C$410.72M-C$79.20N/A

Summary

Knight Therapeutics beats Aurora Cannabis on 11 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GUD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GUD vs. The Competition

MetricKnight TherapeuticsDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$619.43MC$1.08BC$5.06BC$4.30B
Dividend YieldN/A2.99%45.74%6.91%
P/E Ratio-38.19506.89175.0426.30
Price / Sales1.868,576.282,438.792,104.96
Price / Cash3.859.9533.1269.79
Price / Book0.816.895.043.54
Net Income-C$17.44MC$139.92MC$103.36MC$261.62M
7 Day Performance-0.65%0.18%1.02%1.10%
1 Month Performance6.82%1.06%5.75%3.86%
1 Year Performance23.68%22.56%7.43%26.07%

Knight Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.4292 of 5 stars
C$9.56
+5.1%
C$2.26
-76.3%
+1,029.2%C$521.40MC$275.88M-0.121,130Gap Up
OGI
Organigram
3.0063 of 5 stars
C$2.48
-1.2%
C$3.85
+55.2%
+310.6%C$255.44MC$149.21M-0.99984Analyst Forecast
Analyst Revision
Gap Up
WEED
Canopy Growth
0.0561 of 5 stars
C$13.28
+3.5%
C$3.20
-75.9%
+921.4%C$996.66MC$362.24M-0.622,700Gap Up
CPH
Cipher Pharmaceuticals
0 of 5 stars
C$8.69
-1.5%
C$8.75
+0.7%
+144.8%C$209.52MC$21.16M7.905
CRDL
Cardiol Therapeutics
0 of 5 stars
C$2.95
-2.0%
N/A+261.7%C$201.40MN/A-6.70N/A
CRON
Cronos Group
0.3363 of 5 stars
C$4.02
flat
C$2.77
-31.1%
+54.7%C$1.54BC$87.24M-16.08356Analyst Forecast
High Trading Volume
TLRY
Tilray Brands
0.0041 of 5 stars
C$2.85
+5.2%
C$2.95
+3.5%
-18.0%C$2.30BC$743.25M-4.751,600Gap Down
High Trading Volume
EXE
Extendicare
0.6322 of 5 stars
C$7.67
-0.9%
C$8.00
+4.3%
+8.0%C$639.53MC$1.30B19.1823,000Dividend Announcement
Analyst Forecast
News Coverage
KSI
kneat.com
0 of 5 stars
C$4.14
-2.1%
N/A+50.9%C$349.66MC$34.22M-23.00293
VHI
Vitalhub
0.7151 of 5 stars
C$6.63
+0.2%
C$7.25
+9.4%
+162.9%C$336.08MC$52.51M66.30353

Related Companies and Tools

This page (TSE:GUD) was last updated on 5/21/2024 by MarketBeat.com Staff

From Our Partners